Israel-Based Clearmind Medicine Files Patent Applications for Three Unique Combinations of Future Psychedelic-Based Compounds
Ryan Allway February 22nd, 2023 Psychedelics, Top News The company submitted three provisional patent applications with the United States Patent and Trademark Office to protect the novel combination compounds with SciSparc’s PEA Tel Aviv, Israel / Vancouver, Canada, Feb. 22, 2023 (GLOBE NEWSWIRE) —  Clearmind Medicine Inc. (NASDAQ: CMND) (CSE:... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )